Clik here to view.
CORRECTING and REPLACING BeiGene Completes 450 Million RMB (75 Million USD)...
BEIJING In the release dated November 14, 2014, references to “CITIC Capital Partners” should be “CITIC PE”. The boilerplate for CITIC Capital Partners should be replaced with the CITIC PE...
View ArticleClik here to view.
キャタレントがマイクロン・テクノロジーズを買収
米ニュージャージー州サマセット （ビジネスワイヤ） — 医薬品・生物製剤・コンシューマーヘルス製品向けの先進的送達技術と開発ソリューションを提供する世界的リーダー企業のキャタレント（NYSE:CTLT）は本日、粒径エンジニアリング技術を提供する世界一流企業のマイクロン・テクノロジーズを買収したと発表しました。...
View ArticleClik here to view.
Presbia Flexivue Microlens™ Receives Approval from Korean Ministry of Food...
AMSTERDAM Presbia announced today that its Presbia Flexivue Microlens™ has received regulatory approval from the Korean Ministry of Food and Drug Safety (MFDS) making this new treatment option for...
View ArticleClik here to view.
TechNavio Says Increased Outsourcing Activities Will Positively Affect Profit...
LONDON TechNavio, a tech-focused research firm has published a new report on the Global Oncology Biosimilars Market, which is expected to grow at a CAGR of 29.87 percent from 2014-2018. A good...
View ArticleClik here to view.
Quintiles Named a Best Workplace in South Korea
SEOUL, South Korea Quintiles announced today that it has been recognized as one of South Korea’s Best Workplaces by the Great Place to Work® Institute. This is Quintiles Korea’s first time to...
View ArticleClik here to view.
Verdezyne to Build and Operate World’s First Bio-Based Dodecanedioic Acid...
CARLSBAD, Calif. & KUALA LUMPUR, Malaysia Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, today announced it has reached an agreement...
View ArticleClik here to view.
The Lancet Neurology Publishes Prana’s Huntington Disease Trial
MELBOURNE, Australia Prana Biotechnology (ASX:PBT)(NASDAQ:PRAN) has today announced the results of its Phase 2 trial in Huntington Disease, REACH2HD, has been published online in one of the world’s...
View ArticleClik here to view.
テラヴェクティスがレンチウイルスベクターを使用した治療用ワクチンの第I／II相試験の最新情報を提供
パリ （ビジネスワイヤ） — 完全統合型の創薬・臨床開発バイオテクノロジーを手掛ける企業として治療用ワクチンと免疫療法の開発に傾注するテラヴェクティスは、レンチウイルスベクターを使用した史上初のワクチン接種試験の有望な中間結果を報告します。...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine...
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release...
View ArticleClik here to view.
Rohatyn Group完成向Advance Properties出售Huvepharma 36.6%股权的交易
纽约 (美国商业资讯)–专注于新兴市场的独立投资公司Rohatyn Group (“TRG”)今天宣布，TRG Growth Fund II已完成向Domuschiev家族控股的Advance Properties OOD出售Huvepharma AD 36.6%股权的交易。Huvepharma...
View ArticleClik here to view.
Cell Signaling Technology Wins “Best Antibodies” and “Most Useful Website” at...
WASHINGTON Cell Signaling Technology, a leading provider of antibodies, kits and services, announced today that it has won two Life Science Industry Awards® for “Best Antibodies” and “Most Useful...
View ArticleClik here to view.
ZOLL Files with Japan’s Pharmaceuticals and Medical Devices Agency for New...
CHELMSFORD, Mass. ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical Corp. (AZM), has...
View ArticleClik here to view.
Terumo BCT与Banco de Sangre de Servicios Mutuos就血液处理计划展开合作，采用试验器材协助改善血液供应的安全性
科罗拉多州莱克伍德 (美国商业资讯)–鉴于对基孔肯雅病毒(CHIKV)和登革热在公共卫生方面的担忧，Terumo...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of Docetaxel Injection USP
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE®...
View ArticleClik here to view.
Right.Brain Foundation e.V. Provides Advanced Navigation System to New...
MUNICH King Norodom Sihamoni and Prime Minister Hun Sen of Cambodia attended the inauguration of the first full-scale public Neurology Center that includes a 90-bed, $10.8 million dollar treatment...
View ArticleClik here to view.
CSTが「最も優れた抗体」および「最も有益なウェブサイト」の部門でライフサイエンス・インダストリー・アワードを受賞
ワシントン （ビジネスワイヤ）– 抗体、キット、サービスを提供する一流企業のセル・シグナリング・テクノロジー（CST）は本日、「最も優れた抗体」（Best Antibodies）および「最も有益なウェブサイト」（Most Useful Website）の2部門でライフサイエンス・インダストリー・アワード（Life Science Industry...
View ArticleClik here to view.
Clik here to view.
Merck Submits New Drug Application to the Japanese Pharmaceuticals and...
WHITEHOUSE STATION, N.J. Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a new drug application for omarigliptin, its...
View ArticleClik here to view.
Teduglutide Granted Orphan Drug Designation in Japan
BEDMINSTER, N.J. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today...
View ArticleClik here to view.
Multimodal Technology Will Lead to Increased Adoption of Biometrics in the...
LONDON TechNavio, a tech-focused research firm has published a new report on the Biometrics Market in the APAC Region, which is expected to post a CAGR of 20.5 percent from 2015-2019. The rise in...
View Article